Table 3. Cumulative effect of TNF/TRAF2/ASK1/p38 kinase signaling pathway variants on lung complications risk.
# of Risk Genotypes | Event, N(%) | No Event, N(%) | aOR(95%CI) | P-value |
---|---|---|---|---|
0 to 2 | 41(23.84%) | 131(76.16%) | 1(reference) | |
3 | 56(38.89%) | 88(61.11%) | 2.10(1.23–3.59) | 6.46 × 10−8 |
4 to 5 | 97(48.50%) | 103(51.50%) | 3.95(2.40–6.50) | 6.10 × 10−8 |
P for trend | 1.63 × 10−8 |
aAdjusted for age at surgery, gender, intra-operative transfusion, % DLCO predicted, and chest wall resection.